Additions to the Team a Result of the Company’s Continued Growth Providing Drug Safety Risk Management and Pharmacovigilance Solutions to Life Sciences Organizations
NEW YORK, Jan. 13 /PRNewswire/ -- Intrasphere Technologies (http://www.intrasphere.com), a leading consulting firm that provides business-focused services and solutions to Life Sciences organizations, announces the addition of two subject matter experts to the company’s Drug Safety practice: Axel Hagel and Henry Che.
“We are proud to have Axel and Henry, two pharmaceutical industry veterans, on our team,” said Bill Karl, Co-Founder, Chief Executive Officer, Intrasphere Technologies. “Pharmaceutical companies have a critical responsibility to ensure drug and patient safety. As regulations continue to increase, new risk challenges arise. Intrasphere has the industry expertise, dedicated people and channel alliances to ensure our clients achieve seamless drug safety. Our steady client growth in the safety practice validates Intrasphere as the leading consultancy for drug safety.”
“We are pleased to have Axel and Henry join Intrasphere’s team of elite drug safety consultants during this period of growth,” said John Whitebrook, Vice President and Country Manager, U.K., Intrasphere Technologies. “Their in-depth understanding and experience with global Pharmacovigilance business practices will be instrumental in meeting the unique needs of our growing client base.”
Axel Hagel comes to Intrasphere with extensive experience in the delivery of Pharmacovigilance solutions, including seven years at Relsys International, where he served as Vice President. “He brings with him a deep knowledge of the pharmaceutical business and the regulatory requirements that comprise the industry,” Whitebrook said.
“Intrasphere is a company I have respected for many years, and I am excited about the opportunity to combine my drug safety knowledge and business experience to help meet the needs of the growing client base who operate under dynamic regulatory environments,” Hagel said.
Henry Che joins Intrasphere from CSS Informatics, Inc. where he served as a Principal Consultant. “Henry is a seasoned professional with a deep understanding and knowledge of all facets of the drug safety space,” said Whitebrook.
About Intrasphere’s Drug Safety Practice
Intrasphere takes an integrated approach to risk management and adverse events collection, processing and reporting that helps companies to demonstrate to consumers and regulators the appropriate data/analytical capabilities and a commitment to drug safety. We have alliances with all major technology providers and offer technology and services across the gamut of drug safety needs.
About Intrasphere Technologies
Intrasphere Technologies is a consulting firm focused on the Life Sciences industry. Our strategy, business process and technology services are developed to specifically address areas that are most important to our clients including: Drug Safety, Content Management and Portals, Structured Content Management (PharmaCM), Corporate IT, Business Intelligence and Regulatory Compliance, to name a few.
Some of the world’s leading companies, including Pfizer, Johnson & Johnson, Novartis and Eli Lilly, among others, look to Intrasphere as their trusted solutions partner. Founded in 1996, Intrasphere is headquartered in New York City with operations in Europe and Asia.
This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.
CONTACT: Annette DeCicco of Intrasphere Technologies, +1-212-937-8213,
annette.decicco@intrasphere.com
Web site: http://www.intrasphere.com/
